REGISTERED AND RENEWED
on 10 Sep 2019
Last Applicant/ Owned by
BREAKSPEAR WAY
HEMEL HEMPSTEAD
GB
HP2 4TZ
Serial Number
78807740 filed on 06th Feb 2006
Registration Number
3690674 registered on 29th Sep 2009
Correspondent Address
Anthony P. Venturino
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
EUSA PHARMA
Pharmaceutical preparations, namely, drugs, vaccines, immunotherapeutics and biologics, for the treatment of hematology, oncology, neurology and pediatrics diseases and illnesses; pharmaceutical preparations in the nature of proteins and polypeptides for the diagnosis of hematology, oncology, neurology and pediatrics diseases and illnesses
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, drugs, vaccines, immunotherapeutics and biologics, for the treatment of hematology, oncology, neurology and pediatrics diseases and illnesses; pharmaceutical preparations in the nature of proteins and polypeptides for the diagnosis of hematology, oncology, neurology and pediatrics diseases and illnesses
First Use Date in General
31st May 2008
First Use Date in Commerce
31st May 2008
Mark Details
Serial Number
No 78807740
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 072972-75
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th Oct 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 21st Nov 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 21st Nov 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 21st Nov 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 21st Nov 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 21st Nov 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 10th Sep 2019 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| 10th Sep 2019 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 10th Sep 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 10th Sep 2019 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |